Browse Arkansas Code titles and sections
23-79-159. Notification of drug formulary changes.
Arkansas Code — all titles (historical 2020) · legal_authorities
23-79-159. Notification of drug formulary changes.
(a)(1) A health benefit plan that provides prescription drug coverage or contracts with a third party for prescription drug services with tiered copayments shall notify an enrollee presently taking a prescription drug, in writing or electronically at the request of the enrollee, at least sixty (60) days before an increase in the enrollee's financial responsibility as a result of a modification by the health benefit plan to the health benefit plan's drug formulary.
(2) Subdivision (a)(1) of this section does not apply to a generic substitution for a prescription drug.
(b) This section does not apply to coverage for a drug that is determined by a pharmacy and a therapeutics committee to be subject to new safety warnings.
Source: Arkansas Code — historical release 78 (November 6, 2020) · 23-79-159
Stored review status: Historical 2020-11-06 source release; later amendments not reconciled; machine-extracted, not independently legally reviewed; source heading status: text_in_historical_source. A text match is a research starting point; applicability is not established.
Issuing source page ↗
Authority boundary: historical statutory source snapshot not current law.
Open the recorded source website ↗
Record provenance
Stable record: arkansas_code:legal_authorities:23-79-159
Source file: gov.ar.code.title.23.odt
Pages: Not recorded – Not recorded
Passage SHA-256: 6ad0016a3e8d22c28e7d4a24a6a70a9a5c08dbb995e49187c0705d86ebd184ee
Source location: content.xml paragraph 45925
Stored source content
23-79-159. Notification of drug formulary changes.
(a)(1) A health benefit plan that provides prescription drug coverage or contracts with a third party for prescription drug services with tiered copayments shall notify an enrollee presently taking a prescription drug, in writing or electronically at the request of the enrollee, at least sixty (60) days before an increase in the enrollee's financial responsibility as a result of a modification by the health benefit plan to the health benefit plan's drug formulary.
(2) Subdivision (a)(1) of this section does not apply to a generic substitution for a prescription drug.
(b) This section does not apply to coverage for a drug that is determined by a pharmacy and a therapeutics committee to be subject to new safety warnings.
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
No explicit source connection was found. This does not mean there are no relevant authorities.